DCGI Approves Phase II/III Clinical Trial of COVAXIN In The Age Group of 2 To 18 Years M/S Bharat Biotech To Conduct Trials in 525 Healthy Volunteers
Access to this exclusive content is available only to our subscribers
Annual Subscription
₹ 820/year
(Plus ₹ 180 GST)
SUBSCRIBE NOWWith your support, we are able to provide an extensive range of content to you at an accessible subscription model
